Literature DB >> 15507312

Immune responses of swine following DNA immunization with plasmids encoding porcine reproductive and respiratory syndrome virus ORFs 5 and 7, and porcine IL-2 and IFNgamma.

Qiang Xue1, Yong-Gang Zhao, Yan-Jun Zhou, Hua-Ji Qiu, Yun-Feng Wang, Dong-Lai Wu, Zhi-Jun Tian, Guang-Zhi Tong.   

Abstract

In the present study, five eukaryotic double-gene expression plasmids containing porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 and ORF7 genes combined with cDNAs encoding porcine IFNgamma and IL-2 were constructed for evaluation as PRRSV vaccine candidates. After immunization and viral challenge, two of three pigs immunized with pIRESorf5/IFNgamma, one of three pigs immunized with pIRESorf5/IL-2 and one of three pigs immunized with pIRESorf7/IL-2 were protected from lung lesions that were present in other vaccinated and control animals. Virus replication was reduced but not completely prevented in organs of the DNA-vaccinated animals as compared to controls. Therefore, the porcine cytokines IFNgamma and IL-2, delivered in combination with ORF5 or ORF7, may improve the immune efficacy of DNA vaccines against PRRSV.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507312     DOI: 10.1016/j.vetimm.2004.09.021

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  9 in total

1.  Immunopotentiation of four natural adjuvants co-administered with a highly pathogenic porcine reproductive and respiratory syndrome virus glycoprotein 5 subunit.

Authors:  Jun Peng; Yanmei Yuan; Si Shen; Zhongxiang Niu; Yijun Du; Jiaqiang Wu; Jun Li; Jiang Yu; Tao Wang; Jinbao Wang
Journal:  Virus Genes       Date:  2016-02-08       Impact factor: 2.332

2.  Comparative measurement of cell-mediated immune responses of swine to the M and N proteins of porcine reproductive and respiratory syndrome virus.

Authors:  Hyun-Jeong Jeong; Young-Jo Song; Sang-Won Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Gun-Woo Ha; Jin-Sik Oh; Youn-Kyoung Oh; In-Soo Choi
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

3.  Importation and Recombination Are Responsible for the Latest Emergence of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus in China.

Authors:  Kuan Zhao; Chao Ye; Xiao-Bo Chang; Cheng-Gang Jiang; Shu-Jie Wang; Xue-Hui Cai; Guang-Zhi Tong; Zhi-Jun Tian; Mang Shi; Tong-Qing An
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

Review 4.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

5.  Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-κB signaling pathway.

Authors:  Yi Fu; Rong Quan; Hexiao Zhang; Jun Hou; Jun Tang; Wen-hai Feng
Journal:  J Virol       Date:  2012-05-09       Impact factor: 5.103

6.  Immune responses in pigs induced by recombinant DNA vaccine co-expressing swine IL-18 and membrane protein of porcine reproductive and respiratory syndrome virus.

Authors:  Xiaodong Zhang; Xiaoli Wang; Lianzhi Mu; Zhuang Ding
Journal:  Int J Mol Sci       Date:  2012-05-11       Impact factor: 6.208

Review 7.  Porcine reproductive and respiratory syndrome virus vaccine does not fit in classical vaccinology.

Authors:  Young S Lyoo
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

8.  Immunisation of pigs with a major envelope protein sub-unit vaccine against porcine reproductive and respiratory syndrome virus (PRRSV) results in enhanced clinical disease following experimental challenge.

Authors:  Cinta Prieto; Francisco Javier Martínez-Lobo; Francisco Díez-Fuertes; Patricia Aguilar-Calvo; Isabel Simarro; José María Castro
Journal:  Vet J       Date:  2010-08-14       Impact factor: 2.688

Review 9.  Recent Advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like Research in China: Molecular Characterization, Pathogenicity, and Control.

Authors:  Ying Yu; Qiaoya Zhang; Zhi Cao; Yan-Dong Tang; Dasong Xia; Gang Wang; Hu Shan
Journal:  Front Microbiol       Date:  2022-01-11       Impact factor: 5.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.